NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,171,868 | +154.8% | 134,481 | +848.7% | 0.01% | +75.0% |
| Q1 2023 | $852,484 | -99.9% | 14,175 | -19.0% | 0.00% | -55.6% |
| Q4 2021 | $1,313,900,000 | -37.9% | 17,500 | -3.8% | 0.01% | -43.8% |
| Q3 2021 | $2,114,294,000 | -67.7% | 18,200 | -51.8% | 0.02% | -73.8% |
| Q4 2020 | $6,540,219,000 | +401140.4% | 37,796 | +56.2% | 0.06% | +144.0% |
| Q1 2020 | $1,630,000 | -30.5% | 24,201 | -13.0% | 0.02% | +38.9% |
| Q4 2019 | $2,346,000 | -23.9% | 27,831 | -32.4% | 0.02% | -35.7% |
| Q3 2019 | $3,081,000 | +52.8% | 41,200 | +29.2% | 0.03% | +55.6% |
| Q2 2019 | $2,017,000 | – | 31,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |